Can DCIS spread?

This is why DCIS is called in situ or non-invasive. Treatment is still discussed because untreated abnormal cells may later cross the duct boundary in some people, and current tests cannot predict the course with certainty for each individual.

DCIS may involve one area or extend through branching ducts across a broader part of the breast. A larger area within the duct system is still DCIS when the basement membrane remains intact; extent helps determine which operation can remove the affected tissue.

Invasive breast cancer is diagnosed when malignant cells have moved through that boundary into surrounding breast tissue. Pathologists examine biopsy or surgical samples for invasion. If a small invasive focus is found alongside DCIS, the team plans care using the invasive finding as well as the in situ component.

Ask whether the report says pure DCIS, suspected invasion, microinvasion, or invasive carcinoma. Also check how the area seen on mammography compares with the tissue sampled, since a core biopsy examines only part of an imaging abnormality.

Your breast team may recommend lumpectomy when the area can be removed with a suitable breast result, or mastectomy when the distribution makes breast conservation unsuitable. Radiotherapy and hormone therapy may enter the plan according to surgery and pathology, not because DCIS has travelled to distant organs.

Book a clinical review for a new breast or underarm lump, nipple discharge containing blood, new nipple pulling, persistent skin dimpling, or a focal change that remains. These signs can have several explanations and cannot show by themselves whether disease is in situ or invasive.

Following biopsy or surgery, call the treatment team promptly for fever, spreading redness, increasing warmth, worsening swelling, heavy bleeding, or cloudy wound discharge. Go to emergency care for breathing trouble, chest pain, collapse, or a rapidly worsening general condition.

Consider asking: Is the diagnosis entirely DCIS? Was the tissue sufficient to assess invasion? How much of the breast duct system appears involved? Could the final operation reveal information not present in the core biopsy? Will lymph nodes need assessment, and what exact finding would make that relevant?